ARO-HBV
- Generic Name
- ARO-HBV
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
Phase 2
Completed
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Placebo for JNJ-73763989Drug: Placebo for JNJ-56136379
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Janssen Sciences Ireland UC
- Target Recruit Count
- 130
- Registration Number
- NCT04129554
- Locations
- 🇮🇹
Azienda Ospedaliero-Universitaria di Modena, Ospedale di Baggiovara, Modena, Italy
🇬🇧Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧North Manchester General Hospital, Crumpsall, United Kingdom
A Study of JNJ-73763989 in Healthy Japanese Adult Participants
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Janssen Sciences Ireland UC
- Target Recruit Count
- 25
- Registration Number
- NCT04002752
- Locations
- 🇬🇧
PAREXEL International, London, United Kingdom
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection
Phase 2
Completed
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Placebo for JNJ-73763989Drug: Placebo for JNJ-56136379Drug: Nucleos(t)ide Analog (NA)
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Janssen Sciences Ireland UC
- Target Recruit Count
- 471
- Registration Number
- NCT03982186
- Locations
- 🇩🇪
Medizinische Hochschule Hannover, Hannover, Germany
🇩🇪Universitaetsklinikum Leipzig, Leipzig, Germany
🇩🇪Universitatsmedizin der Johannes Gutenberg Universitat Mainz, Mainz, Germany
Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)
Phase 1
Completed
- Conditions
- Hepatitis B
- Interventions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Arrowhead Pharmaceuticals
- Target Recruit Count
- 114
- Registration Number
- NCT03365947
- Locations
- 🇳🇿
Auckland Clinical Studies Limited, Grafton, Auckland, New Zealand
🇳🇿Middlemore Clinical Trials, Papatoetoe, Auckland, New Zealand
🇦🇺Linear Research, Nedlands, Western Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath